SCHEMBL4771247

SCHEMBL4771247

Cc1ccccc1CN(c1ccc(N(C=O)Cc2ccc(C(F)(F)F)nc2)cc1)S(C)(=O)=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
LMNA P02545 1/20 0.39
NPSR1 Q6W5P4 2/20 0.38
HPGD P15428 1/20 0.38
MAPT P10636 2/20 0.37
POLB P06746 1/20 0.37
RECQL P46063 2/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
NR1H2 P55055 2/20 0.35
NR1H3 Q13133 2/20 0.35
KDM4E B2RXH2 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
TRPM8 Q7Z2W7 1/20 0.35
AGTR1 P30556 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
CNR1 P21554 1/20 0.34
CNR2 P34972 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4776637 0.92 RECQL (0.36) ALDH1A1MEN1KMT2ALMNANPSR1
SCHEMBL4770843 0.91 LMNA (0.36) ALDH1A1MEN1KMT2ALMNAPOLB
SCHEMBL4768261 0.90 TRPM8 (0.38) ALDH1A1RECQLTRPM8AGTR1HDAC6
SCHEMBL5571164 0.90 GAA (0.44) ALDH1A1MEN1KMT2ALMNAMAPT
SCHEMBL4773365 0.90 LMNA (0.36) ALDH1A1MEN1KMT2ALMNARECQL
SCHEMBL4770841 0.89 CNR1 (0.37) ALDH1A1MAPTRECQLNR1H2NR1H3
SCHEMBL4772997 0.88 TRPM8 (0.39) ALDH1A1KDM4ESMN1; SMN2TRPM8HDAC6
SCHEMBL4772420 0.87 GAA (0.37) MEN1KMT2ALMNAPOLBRECQL
SCHEMBL4768211 0.87 TRPM8 (0.36) ALDH1A1POLBRECQLTRPM8AGTR1
SCHEMBL4776872 0.87 RECQL (0.39) ALDH1A1LMNAPOLBRECQLNR1H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070135435-A1 Certain chemical entities, compositions, and methods CYTOKINETICS, INCORPORATED 2007-06-14 US claimed
EP-1942888-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS Cytokinetics, Inc. (US) 2008-07-16 EP disclosed
US-20070135435-A1 Certain chemical entities, compositions, and methods CYTOKINETICS, INCORPORATED 2007-06-14 US disclosed
WO-2007056078-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS CYTOKINETICS, INC. (US) 2007-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135435-A1 Certain chemical entities, compositions, and methods KIF5B, KIF2C, PLK1 ALDH1A1 2159/4885MEN1 1302/4885KMT2A 1501/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.